By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today announced that revenues grew 92 percent as product revenues ballooned 84 percent.

Total revenues rose to $1.3 million for the three months ended Sept. 30 from $684,000 a year ago, paced by product revenues, which grew to $1.2 million from $656,000 a year. Product sales were comprised completely of reagent sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.